Fosfomycin Disodium
CAS No. 26016-99-9
Fosfomycin Disodium ( —— )
Catalog No. M21403 CAS No. 26016-99-9
Fosfomycin is a bactericidal low-molecular weight broad-spectrum antibiotic with putative activity against several bacteria including multidrug-resistant Gram-negative bacteria by irreversibly inhibiting an early stage in cell wall synthesis.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
Size | Price / USD | Stock | Quantity |
500MG | 37 | Get Quote |
|
1G | Get Quote | Get Quote |
|
Biological Information
-
Product NameFosfomycin Disodium
-
NoteResearch use only not for human use.
-
Brief DescriptionFosfomycin is a bactericidal low-molecular weight broad-spectrum antibiotic with putative activity against several bacteria including multidrug-resistant Gram-negative bacteria by irreversibly inhibiting an early stage in cell wall synthesis.
-
DescriptionFosfomycin is a bactericidal low-molecular weight broad-spectrum antibiotic with putative activity against several bacteria including multidrug-resistant Gram-negative bacteria by irreversibly inhibiting an early stage in cell wall synthesis.
-
Synonyms——
-
PathwayGPCR/G Protein
-
TargetAntibacterial
-
RecptorAntibacterial
-
Research AreaInfection
-
IndicationUrinary Tract InfectionAsymptomatic Bacteriuria
Chemical Information
-
CAS Number26016-99-9
-
Formula Weight182.02
-
Molecular FormulaC3H5Na2O4P
-
Purity>98% (HPLC)
-
SolubilityH2O:36 mg/mL (197.78 mM)
-
SMILESC[C@@H]1O[C@@H]1P([O-])([O-])=O.[Na+].[Na+]
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1.Dijkmans AC et al. Fosfomycin: Pharmacological Clinical and Future Perspectives. Antibiotics (Basel). 2017 Oct 31;6(4). pii: E24.
molnova catalog
related products
-
D-3-Phenyllactic aci...
D-3-Phenyllactic acid is an anti-bacterial agent excreted by Geotrichum candidum inhibits a range of Gram-positive from humans and foodstuffs and Gram-negative bacteria found in humans.
-
Gatifloxacin hydroch...
A fourth-generation fluoroquinolone antibiotic that inhibits the bacterial DNA gyrase and topoisomerase IV.
-
Gatifloxacin
A fourth-generation fluoroquinolone antibiotic that inhibits the bacterial DNA gyrase and topoisomerase IV.